Abiopharma

Clinical trial NCT06651489 updates: 1. completion date: 2026-04-01 → 2026-12-01 2. primary completion date: 2026-04-01 → 2026-12-01

Clinical trial NCT06809595: primary completion date: 2026-11-01 → 2026-08-01.

Clinical trial NCT07654361 updates: 1. completion date: 2029-04-01 → 2028-11-01 2. primary completion date: 2027-03-01 → 2028-09-01

Clinical trial NCT05143970: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06941844 updates: 1. completion date: 2027-05-01 → 2027-02-01 2. primary completion date: 2026-11-01 → 2026-05-20

Clinical trial NCT07251465 updates: 1. completion date: 2026-05-31 → 2026-07-31 2. primary completion date: 2026-05-31 → 2026-07-31

Clinical trial NCT04866134 updates: 1. completion date: 2025-11-01 → 2027-01-01 2. primary completion date: 2025-05-01 → 2026-11-01

Clinical trial NCT07392957 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-31 → 2026-06-16 3. completion date: 2031-05-31 → 2031-06-30 4. primary completion date: 2029-05-31 → 2029-06-30

Clinical trial NCT05071144: collaborators removed: Cedars-Sinai Medical Center.

Clinical trial NCT05095051 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2023-09-01 → 2023-07-05 3. primary completion date: 2023-09-01 → 2023-07-05 4. enrollment: 33 → 15 participants 5. enrollment type: ESTIMATED → ACTUAL